Biografie Nirad
Nirad Jain is a partner in Bain & Company's New York office. He co-leads Bain’s global Healthcare Private Equity and Corporate M&A practices.
Nirad has almost 20 years of management consulting experience, partnering with corporate clients and financial investors to drive results. He has led more than 200 client engagements across the healthcare value chain, including diligence, corporate M&A, transformation, performance improvement and strategy work in the services, payer, provider, medical device and pharmaceuticals sectors.
He has built significant expertise at the intersection of private equity and healthcare and is frequently cited in the media, including appearances on Bloomberg TV, The New York Times, The Wall Street Journal, Reuters, CNBC, Forbes, Buyouts and many others around the globe.
Prior to joining Bain in 2005, Nirad worked for another consulting confirm in New York, where he advised clients on growth and M&A strategies. He also previously worked in the not-for-profit sector.
Nirad holds an MBA from The Wharton School, a Master of Science from Stanford University and a Bachelor of Science, with honors, from Columbia University.
Recent Insights
- “ Healthcare and Covid-19: The Aftershocks,” Dry Powder: The Private Equity Podcast, 11. Juni 2020, Podcast
- “Healthcare and Covid-19: The Earthquake,” Dry Powder: The Private Equity Podcast, 4. Juni 2020, Podcast
- “Megamergers Boost Healthcare M&A to New High,” Snap Chart, 23. März 2020
- “Private Equity Investors Flock to Resilient Healthcare Industry,” Snap Chart, 18. März 2020
- “Maintaining Momentum in Healthcare Private Equity,” Video, 9. März 2020
- “Welcome Letter: Healthcare Private Equity and Corporate M&A Report 2020 ,” Report, 8. März 2020
- “Healthcare Private Equity Market 2019: The Year in Review ,” Report, 8. März 2020
- “North America: Private Equity Flocks to Healthcare, Intensifying Competition ,” Report, 8. März 2020
- “2020 and Beyond: Strong Fundamentals Will Keep Healthcare Deals Going Strong,” Report, 8. März 2020
- “Private Equity Investors Flock to Healthcare Assets as a Safe Haven,” Snap Chart, 21. Mai 2019